Copanlisib free base

Copanlisib is a potent phosphoinositide 3-kinase (PI3K) inhibitor that inhibits tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is often associated with tumorigenesis, and dysregulation of the PI3K signaling pathway may contribute to tumor resistance to a variety of antitumor drugs.
Supplier Alfa Cytology
Product # BC0136
Pricing 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, inquire
Feedback